Search

Displaying results 9601 - 9610 of 10000 in total
  1. Drug

    Theralizumab

    go.drugbank.com/drugs/DB15717
    Investigational

    Theralizumab is a humanized anti-CD28 monoclonal antibody designed for treating autoimmune diseases and cancer.

  2. Drug

    Maritime pine extract

    go.drugbank.com/drugs/DB15786
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Inactivated SARS-Cov-2 Vaccine

    go.drugbank.com/drugs/DB15862
    Investigational

    This strain was isolated from a patient in Wuhan, cultivated in a Vero cell line, and then subsequently inactivated using B-propiolactone.

  4. Drug

    Human Amniotic Fluid

    go.drugbank.com/drugs/DB15871
    Investigational

    Human amniotic fluid is the liquid surrounding the human embryo and fetus. Physically, the fluid provides protection through cushioning. Chemically, the fluid provides protection through its inherent antibacterial properties. The fluid c...

  5. Drug

    Chamazulene

    go.drugbank.com/drugs/DB15931
    Experimental

    Categories: Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2D6 Inhibitors
  6. Drug

    Troclosene

    go.drugbank.com/drugs/DB15960
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  7. Drug

    Cinnamon oil

    go.drugbank.com/drugs/DB15986
    ApprovedInvestigational

    Categories: Cytochrome P-450 CYP1A2 Inhibitors, Cytochrome P-450 CYP2C9 InhibitorsProducts: Nwk A-FV
  8. Drug

    Triacetin

    go.drugbank.com/drugs/DB16005
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  9. Drug

    GW810781

    go.drugbank.com/drugs/DB16032
    Investigational

    GW810781 is under investigation in clinical trial NCT00046332 (A Study Comparing 4 Doses of GW810781 Versus Placebo in Hiv-infected Patients).

  10. Drug

    JBPOS0101

    go.drugbank.com/drugs/DB16034
    Investigational

    JBPOS0101 is under investigation in clinical trial NCT03976076 (A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients).

    Categories: Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A4 Inducers